Skip to content
Recall Observatory FDA recall evidence

Exact FDA event identifier

Event 88936

1 recalled-product record grouped only because every row carries this exact official event ID.

Open FDA event record

Event summary

Timeline bucket
October 27, 2021
Product types
Drug
Classifications
Class II
Statuses
Terminated
Recalling firm wording
Teva Pharmaceuticals USA

Dossier provenance

Source snapshots represented here

  • openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Complete imported group

Every recalled product in this event

1 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 1

Cartia XT (Diltiazem Hydrochloride Extended-Release Capsules, USP) 120 mg, Rx Only, 90 capsules, labelled as (a) Manufactured By: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054; (b) Manufactured By: Actavis Laboratories FL. Inc, Fort Lauderdale FL. 33314 USA, Distributed by Avista Pharma Inc. Parsippany, NJ 07054 USA. NDC 62037-597-90

D-0232-2022
Recall number
D-0232-2022
Initiated
October 27, 2021
Classification
Class II
Status
Terminated
Recalling firm
Teva Pharmaceuticals USA
Quantity
32316 bottles

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
Labelling: Incorrect Exp. Date

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labelling: Incorrect Exp. Date

Code information

Lot # 100023805, Exp. Date 05/2023

Distribution pattern

Distributed Nationwide in the USA